George Malouly
About George Malouly
George Malouly is the Director of Field Market Access at BeiGene in Los Angeles County, California, with extensive experience in market access and oncology care settings.
Current Role at BeiGene
George Malouly currently serves as Director, Field Market Access at BeiGene. He operates out of Los Angeles County, California, United States. In this role, he oversees market access strategies aimed at securing favorable formulary status for BeiGene's biopharmaceutical products. His work involves engaging with both national and regional managed care landscapes to navigate and optimize product accessibility and reimbursement.
Previous Experience at Celgene
Before joining BeiGene, George Malouly worked at Celgene as a Senior Market Access Executive - U.S. Payer Markets for 14 years, from 2006 to 2020. During his tenure, he led the pre-launch market access strategy for significant advancements such as CAR-T cell therapy and CC486. He also gained recognition for his ability to implement managed markets pull-through initiatives, both nationally and regionally.
Background in Oncology Sales at Novartis
George Malouly has extensive experience in oncology sales, having served at Novartis in multiple capacities. From 2001 to 2006, he was involved in Senior Sales Management focusing on oncology. Prior to that, he held the role of Corporate Account Manager from 1993 to 2001, wherein he developed strategic account plans and executed product launch strategies that contributed to positive access outcomes for Novartis' oncology products.
Early Career and National Account Management at Sandoz
In the early stages of his career, George Malouly was employed at Sandoz as a National Account Manager from 1994 to 1996. During his time at Sandoz, he honed his skills in strategic contracting and rebate programs, achieving notable successes in formulary status wins. This experience laid the foundation for his later roles in market access and strategy.
Educational Background
George Malouly received his education from The University of Texas at El Paso, where he earned a Bachelor of Business Administration (BBA). This academic background provided him with a strong foundation in business principles, which he has effectively applied throughout his career in market access and strategic account management within the biopharmaceutical industry.